LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma

Clinical trial NCT00062868 · COMPLETED

Trial details

NCT number: NCT00062868
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Disease Non Hodgkin Lymphoma Lymphoepithelioma Leiomyosarcoma

Start date: 2003-09-01
Primary completion: 2014-04-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.